| Literature DB >> 33514672 |
Erika Mosor1, Paul Studenic2,3, Alessia Alunno4, Ivan Padjen5,6, Wendy Olsder7,8, Sofia Ramiro9,10, Ilaria Bini7,11, Nele Caeyers12,13, Laure Gossec14,15, Marios Kouloumas16, Elena Nikiphorou17,18, Simon Stones19,20, Tanita-Christina Wilhelmer7,21, Tanja A Stamm22.
Abstract
INTRODUCTION: Although patient-reported outcome measures (PROMs) are increasingly used in clinical practice and research, it is unclear whether these instruments cover the perspective of young people with inflammatory arthritis (IA). The aims of this study were to explore whether PROMs commonly used in IA adequately cover the perspective of young people from different European countries.Entities:
Keywords: arthritis; patient-reported outcome measures; qualitative research
Year: 2021 PMID: 33514672 PMCID: PMC7849893 DOI: 10.1136/rmdopen-2020-001517
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
PROMs selected for discussion in the focus groups
| Name of instrument and reference | Main concept | Use in FGs |
| The Health Assessment Questionnaire | Functioning | RA/JIA/Still’s disease, PsA |
| Bath Ankylosing Spondylitis Functional Index | Functioning | SpA |
| Single item scale for assessing pain | Pain | All FGs |
| Single item scale for assessing disease activity—Patient Global Assessment | Disease activity | All FGs |
| Functional Assessment of Chronic Illness Therapy-Fatigue | Fatigue | All FGs |
| The 36-Item Short Form Health Survey | General health | All FGs |
FGs, focus groups; JIA, juvenile idiopathic arthritis; PROMs, patient-reported outcome measures; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis.
Figure 1Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.
Characteristics of participants
| Disease area | RA/JIA/Still’s disease | SpA | PsA | All |
| N | 21 | 15 | 17 | 53 |
| Women, n (%) | 17 (81.0) | 7 (46.7) | 14 (82.4) | 38 (71.7) |
| Age (±SD) participants* | 28 (±4) | 28 (±5) | 28 (±5) | 28 (±5) |
| Disease duration in years (±SD)* | 11 (±9) | 6 (±5) | 5 (±4) | 8 (±7) |
| Multimorbidity, n (%) | 6 (28.6) | 9 (60.0) | 7 (50.0) | 22 (41.5) |
| Current medication, n (%) | ||||
| cDMARDs | 14 (66.7) | 3 (20.0) | 7 (41.2) | 24 (45.3) |
| bDMARDs | 14 (66.7) | 6 (40.0) | 7 (41.2) | 27 (50.9) |
| tsDMARDs | 0 | 0 | 1 (5.9) | 1 (1.9) |
| Corticosteroids | 9 (42.9) | 1 (6.7) | 1 (5.9) | 11 (20.8) |
| NSAIDs | 8 (38.1) | 7 (46.7) | 5 (29.4) | 20 (37.7) |
| Educational level, n (%) | ||||
| Lower and/or upper secondary education (ISCED levels 2 and 3) | 4 (19.0) | 4 (26.7) | 4 (23.5) | 12 (22.6) |
| Post-secondary non-tertiary education and short-cycle tertiary education (ISCED levels 4 and 5) | 3 (14.3) | 3 (20.0) | 4 (23.5) | 10 (18.9) |
| Bachelor’s, Master’s, Doctoral or equivalent levels (ISCED levels 6, 7, 8) | 14 (66.7) | 8 (53.3) | 9 (52.9) | 31 (58.5) |
| Employment status, n (%) | ||||
| Full-time (30 hours or more) per week | 9 (42.9) | 8 (53.3) | 7 (41.2) | 24 (45.3) |
| Part-time up to 30 hours per week | 3 (14.3) | 3 (20.0) | 4 (23.5) | 10 (18.9) |
| Education/internship/student | 5 (23.8) | 4 (26.7) | 5 (29.4) | 14 (26.4) |
| Unemployed | 4 (19.0) | 1 (6.7) | 1 (5.9) | 6 (11.3) |
| Maternity leave/sabbatical | 0 | 0 | 1 (5.9) | 1 (1.9) |
| Self-reported activity level compared with other people of the same age, n (%) | ||||
| Physically more active | 4 (19.0) | 4 (26.7) | 3 (17.6) | 11 (20.8) |
| About as active | 7 (33.3) | 5 (33.3) | 10 (58.8) | 22 (41.5) |
| Less active | 10 (47.6) | 6 (40.0) | 4 (23.5) | 20 (37.7) |
N total number of participants.
n (%) number of participants (percentage).
*Age (±SD), mean age (SD).
bDMARDs, biological disease-modifying anti-rheumatic drugs; cDMARDs, conventional disease-modifying anti-rheumatic drugs; ISCED, International Standard Classification of Education; JIA, juvenile idiopathic arthritis; NSAIDs, non-steroidal anti-inflammatory drugs; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; tsDMARDs, targeted synthetic disease-modifying anti-rheumatic drugs.
Six higher level and 48 lower level concepts of suggested adaptions of PROMs according to young people with IA
| Higher level concepts | Lower level concepts | Quotes from interview transcripts |
| Information, transparency and clarity regarding the purpose of PROMs are often missing | Reasons for using PROMs are often not known Need for definition/explanation of terms Uncertainty what to tick Questions are incorrectly or not answered Questions incite anxiety and/or fear Feedback on PROM results is appreciated Information about PROM results is available for members of the healthcare team | |
| PROMs on daily functioning were seen as outdated | PROMs are not up to date Inappropriate questions for young people Items relevant to young people need to be added Questions (wording) need to be reformulated PROMs should be developed for different age groups | |
| Relevant issues are often not sufficiently addressed when assessing PROs in young people | Future plans for life Education Work and career goals Intimate relationships Sexuality Body image and appearance Family planning Self-management Use and outcomes of non-pharmacological treatments Use of technological/assistive devices Diet and food intake Psychosocial aspects of being chronically ill Social life, including hobbies and sports Mobility—commuting on public transport and driving Changing/holding a certain position | |
| The scoring on a rating scale sometimes differs from the current health situation | Scoring differently than the situation was experienced (on purpose to achieve something) Wish for getting in touch/being recognised Changes in disease management To show a flare in between visits (lack of continuous monitoring) | |
| The individual life situation of young people adds essential importance to the results of PROMs | PROMs should not only be used for data gathering, but as a mediator for discussions with HPs Individualisation of outcome assessment would be appreciated Using comprehensive PROMs Using single scales only is insufficient Clear reference points are often missing (with and without medication, compared with someone without a disease or another patient in remission) Time frame is not adequate, for example, a longer time frame for scoring pain to include flares Substantial fluctuation of pain levels is difficult to score Forgetting the extent of pain over time Interpreting results is difficult from the patients’ perspective Losing important information (if PROs are quantified only, qualitative information, for example, in a discussion with the health professional, is missing) Missing overview about disease course (patients would appreciate an overview regarding their scores over time) Patients prefer NRS to VAS Patients were confronted with differently formulated PGA questions | |
| The use of technology for data acquisition was suggested by some young people | New formats for collecting PROs are needed Continuous monitoring supports self-management Use of a symptom diary/log could be facilitated by digital technologies Time-saving for patients and HPs |
HAQ, Health Assessment Questionnaire; HPs, healthcare professionals; IA, inflammatory arthritis; JIA, juvenile idiopathic arthritis; NRS, Numeric Rating Scale; PGA, Patient Global Assessment; PROMs, patient-reported outcome measures; PROs, patient-reported outcomes; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; VAS, Visual Analogue Scale.
Similarities and differences of concepts addressed on a disease specific and country level
| Higher level concept | Lower level concept (LLC) | LLC per disease group | LLCs per country | |||||
| 6 | 48 | RA/JIA/Still’s disease | PsA | SpA | AT | HR | NL | IT |
| 1. Information, transparency and clarity regarding the purpose of PROMs are often missing | + | + | + | + | + | + | + | |
| + | + | + | + | + | + | + | ||
| + | + | + | + | + | + | + | ||
| Questions are incorrectly or not answered | + | + | + | + | ||||
| Questions incite anxiety and/or fear | + | + | + | + | ||||
| + | + | + | + | + | + | + | ||
| Information about PROM results is available for members of the healthcare team | + | + | + | + | ||||
| 2. PROMs on daily functioning were seen as outdated | + | + | + | + | + | + | + | |
| + | + | + | + | + | + | + | ||
| + | + | + | + | + | + | + | ||
| Questions (wording) need to be reformulated | + | + | + | + | + | + | ||
| PROMs should be developed for different age groups | + | + | ||||||
| 3. Relevant issues are often not sufficiently addressed when assessing PROs in young people | Future plans for life | + | + | + | + | + | + | |
| Education | + | + | + | + | + | |||
| Work and career goals | + | + | + | + | + | |||
| Intimate relationships | + | + | + | + | + | |||
| Sexuality | + | + | + | + | ||||
| Body image and appearance | + | + | + | |||||
| Family planning | + | + | + | + | ||||
| Self-management | + | + | + | + | ||||
| + | + | + | + | + | + | + | ||
| Use of technological/assistive devices | + | + | + | + | ||||
| Diet and food intake | + | + | + | + | ||||
| + | + | + | + | + | + | + | ||
| + | + | + | + | + | + | + | ||
| Mobility—commuting on public transport and driving | + | + | + | + | + | |||
| Changing/holding a certain position | + | + | + | |||||
| 4. The scoring on a rating scale sometimes differs from the current health situation | + | + | + | + | + | + | + | |
| Wish for getting in touch/being recognised | + | + | ||||||
| Changes in disease management | + | + | + | |||||
| To show a flare in between visits (lack of continuous monitoring) | + | + | + | |||||
| 5. The individual life situation of young people adds essential importance to the results of PROMs | PROMs should not only be used for data gathering, but as a mediator for discussions with HPs | + | + | + | ||||
| + | + | + | + | + | + | + | ||
| + | + | + | + | + | + | + | ||
| + | + | + | + | + | + | + | ||
| Clear reference points are often missing (with and without medication, compared with someone without a disease or another patient in remission) | + | + | + | + | + | |||
| + | + | + | + | + | + | + | ||
| Substantial fluctuation of pain levels is difficult to score | + | + | ||||||
| + | + | + | + | + | + | + | ||
| Interpreting results is difficult from the patients’ perspective | + | + | + | + | + | + | ||
| + | + | + | + | + | + | + | ||
| Missing overview about disease course (patient would appreciate an overview regarding their scores over time) | + | + | + | + | + | + | ||
| Patients prefer NRS to VAS | + | + | + | + | + | + | ||
| + | + | + | + | + | + | + | ||
| 6. The use of technology for data acquisition was suggested by some young people | New formats for collecting PROs are needed | + | + | + | + | + | + | |
| Continuous monitoring supports self-management | + | + | + | + | + | |||
| Use of a symptom diary/log could be facilitated by digital technologies | + | + | + | + | + | |||
| Time-saving for patients and HPs | + | + | ||||||
Concepts in BOLD were mentioned in all diseases and all countries.
+=LLC which had been mentioned.
AT, Austria; HPs, health professionals; HR, Croatia; IT, Italy; JIA, juvenile idiopathic arthritis; NL, the Netherlands; NRS, Numeric Rating Scale; PGA, Patient Global Assessment; PROMs, patient-reported outcome measures; PROs, patient-reported outcomes; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; VAS, Visual Analogue Scale.